William Hoos is a venture partner at Pilot Mountain Ventures and founder and CEO of NQ Oncology. He also advises medical diagnostic, device, pharmaceutical and patient advocate organizations globally on product development and market strategy. His past clients include OncoPlexDx (acquired by NantOmics), Pancreatic Cancer Action Network, Skyline Diagnostics BV and Vanda Pharmaceuticals.
Mr. Hoos was previously with Philips Home Healthcare Solutions (Respironics) as Director of New Product Commercialization, where he led the Sleep Well Ventures business in bringing key new products to market. Sleep Well Ventures was established by Respironics as an internal venture group responsible for creating a portfolio of medical devices through business development, acquisitions, and equity investments. While there, Mr. Hoos led new product marketing, strategy and implementation, applied research, clinical trial design, regulatory strategy, and manufacturing. Mr. Hoos led the international launch of a novel insomnia therapy device and designed and defended the US regulatory approval strategy including multiple meetings with the FDA. Additionally, he led the successful integration of an acquisition in light therapy devices and on-time design and launch of their next generation award-winning product.
Prior to Respironics, Mr. Hoos held various roles in R&D and business development. He has also been a software entrepreneur and founded ClinWiki.org which provides crowd sourced clinical trial information. He serves as an Entrepreneur In Residence at Launch Chapel Hill and on the Board of SECU Family House at UNC Hospitals.
Mr. Hoos earned an MBA from Georgia Institute of Technology. He holds a BS Chemistry from Wake Forest University and MS Organic Chemistry from the University of California, Los Angeles.